K Karube1, K Nabeshima, M Ishiguro, M Harada, H Iwasaki. 1. Department of Pathology, School of Medicine, Fukuoka University, Nanakuma 7-45-1, Jonan-ku, Fukuoka 814-0180, Japan. xs255@cis.fukuoka-u.ac.jp
Abstract
BACKGROUND: Malignant peripheral nerve sheath tumour (MPNST) is a highly aggressive malignancy that arises within peripheral nerves, and is associated with poor prognosis. Little is known about the underlying biology of MPNST, especially the mechanisms involved in cell proliferation, invasion, or escape from apoptosis. AIMS: To identify genes differentially expressed in MPNST compared with benign tumours, such as neurofibromas and schwannomas, by means of cDNA microarray analysis. METHODS: Six MPNST cases and five benign cases (three schwannomas and two neurofibromas) were analysed. RESULTS: Six genes (keratin 18, survivin, tenascin C, adenosine deaminase, collagen type VIa3, and collagen type VIIa1) were significantly upregulated in MPNST, whereas one gene, insulin-like growth factor binding protein 6, was downregulated in MPNST. Survivin and tenascin C expression was validated by reverse transcription polymerase chain reaction. Immunohistochemistry confirmed upregulation of survivin in MPNST at the protein level in six of eight cases compared with benign tumours. Tenascin C was also expressed at the invasive front and tumorous stroma in all MPNST cases. MPNST cells expressed tenascin C in four of nine cases. CONCLUSIONS: Survivin and tenascin C may be associated with the malignant potential of MPNST and could be considered as potential therapeutic targets.
BACKGROUND:Malignant peripheral nerve sheath tumour (MPNST) is a highly aggressive malignancy that arises within peripheral nerves, and is associated with poor prognosis. Little is known about the underlying biology of MPNST, especially the mechanisms involved in cell proliferation, invasion, or escape from apoptosis. AIMS: To identify genes differentially expressed in MPNST compared with benign tumours, such as neurofibromas and schwannomas, by means of cDNA microarray analysis. METHODS: Six MPNST cases and five benign cases (three schwannomas and two neurofibromas) were analysed. RESULTS: Six genes (keratin 18, survivin, tenascin C, adenosine deaminase, collagen type VIa3, and collagen type VIIa1) were significantly upregulated in MPNST, whereas one gene, insulin-like growth factor binding protein 6, was downregulated in MPNST. Survivin and tenascin C expression was validated by reverse transcription polymerase chain reaction. Immunohistochemistry confirmed upregulation of survivin in MPNST at the protein level in six of eight cases compared with benign tumours. Tenascin C was also expressed at the invasive front and tumorous stroma in all MPNST cases. MPNST cells expressed tenascin C in four of nine cases. CONCLUSIONS: Survivin and tenascin C may be associated with the malignant potential of MPNST and could be considered as potential therapeutic targets.
Authors: S Stilgenbauer; C Schaffner; D Winkler; G Ott; E Leupolt; M Bentz; P Möller; H K Müller-Hermelink; M R James; P Lichter; H Döhner Journal: Ann Oncol Date: 2000 Impact factor: 32.976
Authors: F Li; E J Ackermann; C F Bennett; A L Rothermel; J Plescia; S Tognin; A Villa; P C Marchisio; D C Altieri Journal: Nat Cell Biol Date: 1999-12 Impact factor: 28.824
Authors: Markus P Ghadimi; Eric D Young; Roman Belousov; Yiqun Zhang; Gonzalo Lopez; Kristelle Lusby; Christine Kivlin; Elizabeth G Demicco; Chad J Creighton; Alexander J Lazar; Raphael E Pollock; Dina Lev Journal: Clin Cancer Res Date: 2012-03-08 Impact factor: 13.801
Authors: Stine H Kresse; Magne Skårn; Hege O Ohnstad; Heidi M Namløs; Bodil Bjerkehagen; Ola Myklebost; Leonardo A Meza-Zepeda Journal: Mol Cancer Date: 2008-06-03 Impact factor: 27.401
Authors: Su-Jin Park; Birgit Sawitzki; Lan Kluwe; Victor F Mautner; Nikola Holtkamp; Andreas Kurtz Journal: BMC Med Date: 2013-04-23 Impact factor: 8.775
Authors: N Presneau; M Eskandarpour; T Shemais; S Henderson; D Halai; R Tirabosco; A M Flanagan Journal: Br J Cancer Date: 2012-11-22 Impact factor: 7.640
Authors: Karin S G Cunha; Anabela C Caruso; Paulo A S de Faria; Licínio E da Silva; Andréa R C Pires; Mauro Geller; Vânia S Lopes; Rodrigo S de Moura-Neto Journal: Clinics (Sao Paulo) Date: 2012-08 Impact factor: 2.365
Authors: Rita Alaggio; Riccardo Turrini; Daniela Boldrin; Anna Merlo; Claudio Gambini; Andrea Ferrari; Patrizia Dall'igna; Cheryl M Coffin; Annalisa Martines; Laura Bonaldi; Gian Luca De Salvo; Paola Zanovello; Antonio Rosato Journal: PLoS One Date: 2013-11-26 Impact factor: 3.240